Neoplasm, Residual

"Neoplasm, Residual" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Remnant of a tumor or cancer after primary, potentially curative therapy.

Descriptor ID	D018365
MeSH Number(s)	C04.697.700 C23.550.727.700
Concept/Terms	Neoplasm, Residual Neoplasm, Residual Residual Neoplasms Residual Neoplasm Minimal Residual Disease Minimal Disease, Residual Residual Minimal Disease Residual Minimal Diseases Residual Disease, Minimal Minimal Residual Diseases Residual Cancer Residual Cancer Cancer, Residual Residual Cancers Residual Tumor Residual Tumor Residual Tumors Residual Tumour Residual Tumours Tumour, Residual

Below are MeSH descriptors whose meaning is more general than "Neoplasm, Residual".

Diseases [C]
Neoplasms [C04]
Neoplastic Processes [C04.697]
Neoplasm, Residual [C04.697.700]
Pathological Conditions, Signs and Symptoms [C23]
Pathologic Processes [C23.550]
Neoplastic Processes [C23.550.727]
Neoplasm, Residual [C23.550.727.700]

Below are MeSH descriptors whose meaning is related to "Neoplasm, Residual".

Below are MeSH descriptors whose meaning is more specific than "Neoplasm, Residual".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Neoplasm, Residual" by people in this website by year, and whether "Neoplasm, Residual" was a major or minor topic of these publications.

Bar chart showing 70 publications over 26 distinct years, with a maximum of 9 publications in 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	0	1	1
1997	0	1	1
1999	1	2	3
2000	0	3	3
2001	0	3	3
2003	0	2	2
2004	0	3	3
2005	0	1	1
2006	0	1	1
2008	0	2	2
2009	0	1	1
2010	2	2	4
2011	0	1	1
2012	1	1	2
2013	0	3	3
2014	1	3	4
2015	1	5	6
2016	1	3	4
2017	0	3	3
2018	1	2	3
2019	2	0	2
2020	1	8	9
2021	1	1	2
2022	0	3	3
2024	0	2	2
2025	0	1	1

Below are the most recent publications written about "Neoplasm, Residual" by people in Profiles.

King AJ, Steenkamp R, Graumann O, Wah TM, Alcorn D, Nielsen TK, de Kerviler E, Zondervan PJ, Walkden M, Lagerveld B, Van Strijen M, Keeley FX, Breen DJ. Risk Factors for Residual Unablated Tumour Following CT-Guided Percutaneous Renal Cryoablation: Lessons from the EuRECA Registry. Cardiovasc Intervent Radiol. 2025 Feb; 48(2):196-204.

View in: PubMed
Saeed A, Yousuf S, Noverati N, Chen A, Saleem N, Farooq U, Muniraj T, Persaud A, Xiao Y, Kumar A, Schlachterman A, Kowalski T, Adler D, Kamal F. Cold- versus hot-snare endoscopic mucosal resection of colorectal polyps: meta-analysis of randomized controlled trials. Gastrointest Endosc. 2025 06; 101(6):1239-1243.e2.

View in: PubMed
Montagna G, Laws A, Ferrucci M, Mrdutt MM, Sun SX, Bademler S, Balbaloglu H, Balint-Lahat N, Banys-Paluchowski M, Barrio AV, Benson J, Bese N, Boughey JC, Boyle MK, Diego EJ, Eden C, Eller R, Goldschmidt M, Hlavin C, Heidinger M, Jelinska J, Karadeniz Cakmak G, Kesmodel SB, King TA, Kuerer HM, Loesch J, Milardi F, Murawa D, Moo TA, Menes TS, Passeri D, Pastoriza JM, Perhavec A, Pislar N, Polidorio N, Rami A, Ryu JM, Schulz A, Sevilimedu V, Ugurlu MU, Uras C, van Hemert A, Wong SM, Yoo TR, Zhang JQ, Karanlik H, Cabioglu N, Peeters MV, Morrow M, Weber WP. Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+): The OPBC-05/ICARO Study. J Clin Oncol. 2025 03; 43(7):810-820.

View in: PubMed
Zhang YH, Montagna G, Flynn J, Gillespie EF, Mamtani A, Zhang Z, Braunstein LZ, Powell SN, Morrow M, Barrio A, Khan AJ. Outcomes of Breast Cancer Patients with High Volume of Residual Disease Following Neoadjuvant Chemotherapy. Int J Radiat Oncol Biol Phys. 2023 03 01; 115(3):622-628.

View in: PubMed
O'Cearbhaill RE, P?rez-Fidalgo JA, Monk BJ, Tusquets I, McCormick C, Fuentes J, Moore RG, Vulsteke C, Shahin MS, Forget F, Bradley WH, Hietanen S, O'Malley DM, D?rum A, Slomovitz BM, Baumann K, Selle F, Calvert PM, Artioli G, Levy T, Kumar A, Malinowska IA, Li Y, Gupta D, Gonz?lez-Mart?n A. Efficacy of niraparib by time of surgery and postoperative residual disease status: A post hoc analysis of patients in the PRIMA/ENGOT-OV26/GOG-3012 study. Gynecol Oncol. 2022 07; 166(1):36-43.

View in: PubMed
LaFargue CJ, Handley KF, Fleming ND, Nick AM, Chelariu-Raicu A, Fellman B, Castellano T, Ogasawara A, Hom-Tedla M, Blake EA, da Costa AABA, Crim AK, Rauh-Hain A, Westin SN, Coleman RL, Matsuo K, Baiocchi G, Hasegawa K, Moore K, Sood AK. Clinical analysis of pathologic complete responders in advanced-stage ovarian cancer. Gynecol Oncol. 2022 04; 165(1):82-89.

View in: PubMed
Chun JW, Kim J, Chung IY, Ko BS, Kim HJ, Lee JW, Son BH, Ahn SH, Lee SB. Sentinel node biopsy alone for breast cancer patients with residual nodal disease after neoadjuvant chemotherapy. Sci Rep. 2021 04 27; 11(1):9056.

View in: PubMed
Siedlecki J, Pulido J, Priglinger S. Minimal Residual Disease in Neovascular Age-Related Macular Degeneration. Klin Monbl Augenheilkd. 2021 Jun; 238(6):700-702.

View in: PubMed
Wu ZY, Han J, Eom JS, Ahn SH, Ko B. Residual disease after mastectomy. Lancet Oncol. 2020 11; 21(11):e500.

View in: PubMed
Gwark S, Kim J, Kwon NJ, Kim KY, Kim Y, Lee CH, Kim YH, Kim MS, Hong SW, Choi MY, Jeon BH, Chang S, Yu J, Park JY, Lee HJ, Lee SB, Chung IY, Ko BS, Kim HJ, Lee JW, Son BH, Ahn JH, Jung KH, Kim SB, Gong GY, Ahn SH. Analysis of the serial circulating tumor cell count during neoadjuvant chemotherapy in breast cancer patients. Sci Rep. 2020 10 15; 10(1):17466.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement